Objective-To evaluate the efficacy and safety of a carbohydrate restricted versus a low fat diet on weight loss, metabolic markers, body composition, and cardiac function tests in severely obese adolescents.Study design-Subjects were randomized to one of two diets: a high protein, low carbohydrate (20 g/day) diet (HPLC) or low fat (30% of calories) (LF) regimen for 13 weeks; close monitoring was maintained to evaluate safety. After the intervention, no clinical contact was made until followup measurements were obtained at 24 and 36 weeks from baseline. The primary outcome was change in BMI-Z-score at 13, 24, and 36 weeks.Results-Forty-six subjects (24 HPLC, 22 in LF) initiated and 33 subjects completed the intervention; follow-up data were available on approximately half of the subjects. Significant reduction in BMI-Z-score (BMI-Z) was achieved in both groups during intervention, and was significantly greater for the HPLC group (p=0.03). Both groups maintained significant BMI-Z reduction at follow-up; changes were not significantly different between groups. Loss of lean body mass was not spared in the HPLC group. No serious adverse effects were observed related to metabolic profiles, cardiac function, or subjective complaints.
Conclusions-The HPLC diet is a safe and effective option for medically supervised weight loss in severely obese adolescents.
KeywordsObesity; obesity treatment; body composition; hyperlipidemia; insulin resistance; satiety Effective treatment options for childhood and adolescent obesity are limited, particularly for those who are severely obese. The recent report on treatment of childhood obesity from an Expert Committee recommended a staged approach, with greater intensity interventions for those who are severely obese and for whom traditional lifestyle changes have not been successful (1). Identification of effective treatments for severely obese children is very important for at least two reasons. First, the increased prevalence of childhood obesity has been particularly striking in the severe range, i.e., those with BMI for age above the 99 th percentile Corresponding author: Nancy F. Krebs, MD, MS, University of Colorado Denver, 12700 East 19 th Ave -Box C225, Aurora, CO 80045, nancy.krebs@ucdenver.edu. No reprints available from author. Edited by Sherman and WFB The authors declare no conflicts of interest.Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 2,3). Secondly, the risk of significant co-morbidities increases sharply for those in this category (4).
NIH Public AccessOne approach that has been used in selected treatment cente...